Back to 
Woodline Partners LP
Woodline Partners LP
INBX
6 quarters
Position history for Woodline Partners LP's holdings in INHIBRX BIOSCIENCES INC
Yes. Woodline Partners holds 400,892 shares of INBX (Inhibrx Biosciences), worth $38M, as of its Q2 2026 13F filing. It increased the position by 16,459 shares (+4.3%) from Q1 2026. Woodline Partners has held INBX since Q1 2025, across 6 quarterly 13F filings. INBX is 0.1% of Woodline Partners' reported 13F portfolio.
Current Value
$38M
Current Shares
400,892
Total Value Change
+$33M
Total Shares Change
+42,456
Quarter-by-Quarter History